TreatER | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery
01-01-2017
-31-12-2020
Show more information
Organisation
HERANTIS PHARMA OYJ